Loyens & Loeff acted as Dutch corporate counsel to the underwriters with respect to the IPO of InflaRx N.V. on the NASDAQ Global Select Market, under…
InflaRx N.V.’s $100 million initial public offering on the NASDAQ Global Select Market,
Loyens & Loeff acted as Dutch corporate counsel to the underwriters with respect to the IPO of InflaRx N.V. on the NASDAQ Global Select Market, under…